Ketotifen Impurities: Focusing on Quality Control of a Classic Antihistam...

Ketotifen, as a first-generation antihistamine, exerts its effects by strongly blocking H1 histamine receptors, thereby counteracting allergic symptoms such as bronchial smooth muscle contraction an...

See More

Overcoming quality inspection challenges: Complete set of famotidine impuritie...

Famotidine is a third-generation, highly effective H2 receptor antagonist primarily used to inhibit gastric acid secretion, treating conditions such as gastric and duodenal ulcers, and gastroesophag...

See More

Full Range Available Now! Supporting Paclitaxel Impurity Research...

Paclitaxel is a diterpenoid compound isolated and purified from plants of the Taxaceae family. It is a classic anticancer drug widely used globally, known for its ideal efficacy and low toxicity....

See More

Atorvastatin Impurities: A Key Role in Hyperlipidemia Control and Preven...

With the expansion of the atorvastatin market and the emergence of generic versions, drug quality and impurity control have become critical links in ensuring the efficacy and safety of this important...

See More

FDA Approves Wegovy® Pill, Ushering in a New Era of Oral Obesity Tr...

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Wegovy® tablets (containing 25 mg of semaglutide for once-daily oral administration) to help reduce exc...

See More

world first！A New Treatment Option for DPNP and the Critical Control ...

Recently, the Lidocaine Gel Patch (brand name: DeBaiNing®), developed by Tide Pharm, a subsidiary of China Biopharmaceuticals, has been granted approval for a new indication by the Nation...

See More

A Key Strategy for Mastering Pimecrolimus Impurity Quality Control...

Pimecrolimus cream is a non-hormonal topical dermatological formulation. The 1% pimecrolimus cream is approved for the treatment of mild to moderate atopic dermatitis (AD) in non-immunocompromised...

See More

Diverse Options in Influenza Prevention and Control: How to Ensure Drug ...

As the flu season persists, drug quality control becomes a critical link in ensuring public medication safety. Drug impurity reference standards, serving as the "benchmark" in drug quality research,...

See More

Atrasentan Impurities—A Critical Quality Control Factor in IgA Nephro...

In August 2025, atrasentan hydrochloride tablets were officially approved by China‘s National Medical Products Administration (NMPA) for the reduction of proteinuria in adult patients wi...

See More

Full Set In Stock | Adrenaline Impurities Now Shining Bright!...

SZEB specializes in supplying Adrenaline impurity reference standards, including the N-NitrosoAdrenaline series and Adrenaline EP impurity series, to meet diverse experimental needs. Thes...

See More

Combination Nasal Spray Ryaltris® Disrupts the Rhinitis Market: How We...

On November 10th, the compound nasal spray containing Olopatadine Hydrochloride and Mometasone Furoate (brand name: Ryaltris®), jointly developed by Grand Pharmaceutical Group‘s subsidiary...

See More

Xanomeline : A Pioneering Non-Dopaminergic Therapy...

The fixed-dose combination drug Cobenfy (Kar XT), composed of xanomeline and trospium chloride, received FDA approval in September 2024 for the treatment of schizophrenia in adults. This mar...

See More

In Stock | Sacubitril impurity references...

Sacubitril Valsartan Sodium Tablets is the world‘s first commercially available angiotensin receptor-neprilysin inhibitor (ARNI). It was approved for marketing in 2017 by the National Medi...

See More

Udenafil Impurity Control and Scientific Innovation: Professional Pharmac...

Udenafil is a selective phosphodiesterase type 5 (PDE5) inhibitor. It is primarily used for the treatment of male erectile dysfunction (ED) and is also applied in the management of premature ej...

See More

China’s First Domestically Developed Dulaglutide Injection Approved for ...

On August 8, Boan Biotechnology announced that its independently developed Boyouping® (Dulaglutide Injection) has received market approval from the National Medical Products Administration...

See More

Crisaborole is Reshaping Atopic Dermatitis Treatment, Backed by SZEB Q...

Crisaborole is a boron-containing small-molecule anti-inflammatory drug, classified as a non-steroidal topical phosphodiesterase-4 (PDE-4) inhibitor. By inhibiting PDE-4, the drug increases th...

See More

Qilu Pharmaceutical Co.,Ltd.’s Carfilzomib for Injection Approved for M...

Qilu Pharmaceutical Co.,Ltd’s Carfilzomib for Injection has received market approval from the National Medical Products Administration (NMPA) of China for the treatment of adult patie...

See More

First-in-Class: FDA OKs Triple Therapy to Treat Hypertension...

Recently, George Medicines announced that its new drug Widaplik® (containing telmisartan, amlodipine, and indapamide, previously known as GMRx2) has been approved by the U.S. Food and Drug...

See More

LEQEMBI IQLIK™, the first-ever at-home subcutaneous injection for A...

The U.S. FDA has approved the lecanemab-irmb subcutaneous injection (U.S. brand name: LEQEMBI IQLIK™), jointly developed by Biogen and Eisai, for maintenance therapy in early A...

See More

Folic Acid Impurities: Reference Standards for Pharmaceutical Quality Co...

Beyond process-related impurities, factors such as light exposure, high temperatures, or humid conditions can cause the oxidation or degradation of folic acid, leading to the formation of new impurit...

See More